Pharmaceuticals maker Roche has introduced a new diabetes product that it says will lower blood glucose monitoring costs for some patients by thousands of dollars per year.

Roche Holding RHHBY recently announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. With the approval, CGM solution can now be made ...